Your browser doesn't support javascript.
loading
Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centers.
Carlo-Stella, Carmelo; Ricci, Francesca; Dalto, Serena; Mazza, Rita; Malagola, Michele; Patriarca, Francesca; Viviani, Simonetta; Russo, Domenico; Giordano, Laura; Castagna, Luca; Corradini, Paolo; Santoro, Armando.
Afiliação
  • Carlo-Stella C; Department of Hematology and Oncology, Humanitas Cancer Center, and Biostatistical Unit, Humanitas Clinical and Research Center, Milan, Italy; Departments of Medical Biotechnology and Translational Medicine and Hematology, University of Milan, Milan, Italy; Hematology and BMT Unit, Fondazione IRCCS
  • Ricci F; Department of Hematology and Oncology, Humanitas Cancer Center, and Biostatistical Unit, Humanitas Clinical and Research Center, Milan, Italy; Departments of Medical Biotechnology and Translational Medicine and Hematology, University of Milan, Milan, Italy; Hematology and BMT Unit, Fondazione IRCCS
  • Dalto S; Department of Hematology and Oncology, Humanitas Cancer Center, and Biostatistical Unit, Humanitas Clinical and Research Center, Milan, Italy; Departments of Medical Biotechnology and Translational Medicine and Hematology, University of Milan, Milan, Italy; Hematology and BMT Unit, Fondazione IRCCS
  • Mazza R; Department of Hematology and Oncology, Humanitas Cancer Center, and Biostatistical Unit, Humanitas Clinical and Research Center, Milan, Italy; Departments of Medical Biotechnology and Translational Medicine and Hematology, University of Milan, Milan, Italy; Hematology and BMT Unit, Fondazione IRCCS
  • Malagola M; Department of Hematology and Oncology, Humanitas Cancer Center, and Biostatistical Unit, Humanitas Clinical and Research Center, Milan, Italy; Departments of Medical Biotechnology and Translational Medicine and Hematology, University of Milan, Milan, Italy; Hematology and BMT Unit, Fondazione IRCCS
  • Patriarca F; Department of Hematology and Oncology, Humanitas Cancer Center, and Biostatistical Unit, Humanitas Clinical and Research Center, Milan, Italy; Departments of Medical Biotechnology and Translational Medicine and Hematology, University of Milan, Milan, Italy; Hematology and BMT Unit, Fondazione IRCCS
  • Viviani S; Department of Hematology and Oncology, Humanitas Cancer Center, and Biostatistical Unit, Humanitas Clinical and Research Center, Milan, Italy; Departments of Medical Biotechnology and Translational Medicine and Hematology, University of Milan, Milan, Italy; Hematology and BMT Unit, Fondazione IRCCS
  • Russo D; Department of Hematology and Oncology, Humanitas Cancer Center, and Biostatistical Unit, Humanitas Clinical and Research Center, Milan, Italy; Departments of Medical Biotechnology and Translational Medicine and Hematology, University of Milan, Milan, Italy; Hematology and BMT Unit, Fondazione IRCCS
  • Giordano L; Department of Hematology and Oncology, Humanitas Cancer Center, and Biostatistical Unit, Humanitas Clinical and Research Center, Milan, Italy; Departments of Medical Biotechnology and Translational Medicine and Hematology, University of Milan, Milan, Italy; Hematology and BMT Unit, Fondazione IRCCS
  • Castagna L; Department of Hematology and Oncology, Humanitas Cancer Center, and Biostatistical Unit, Humanitas Clinical and Research Center, Milan, Italy; Departments of Medical Biotechnology and Translational Medicine and Hematology, University of Milan, Milan, Italy; Hematology and BMT Unit, Fondazione IRCCS
  • Corradini P; Department of Hematology and Oncology, Humanitas Cancer Center, and Biostatistical Unit, Humanitas Clinical and Research Center, Milan, Italy; Departments of Medical Biotechnology and Translational Medicine and Hematology, University of Milan, Milan, Italy; Hematology and BMT Unit, Fondazione IRCCS
  • Santoro A; Department of Hematology and Oncology, Humanitas Cancer Center, and Biostatistical Unit, Humanitas Clinical and Research Center, Milan, Italy; Departments of Medical Biotechnology and Translational Medicine and Hematology, University of Milan, Milan, Italy; Hematology and BMT Unit, Fondazione IRCCS
Oncologist ; 20(3): 323-8, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25669663
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Imunoconjugados Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Imunoconjugados Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article